Quantcast
Last updated on April 16, 2014 at 21:24 EDT

Latest Becton Dickinson Stories

2013-06-04 08:29:19

FRANKLIN LAKES, N.J. and OLATHE, Kan., June 4, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Heart to Heart International, a nonprofit humanitarian medical aid organization, are collaborating on their third joint volunteer initiative to strengthen healthcare in Haiti. A team of 14 BD employees from around the world will build upon the progress made by their colleagues in 2012. This year the volunteers will visit Haiti for...

2013-06-03 08:28:19

BD Neopak(TM) Prefillable Syringe System Commercially Launched Worldwide FRANKLIN LAKES, N.J., June 3, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the launch of BD Neopak(TM), a new glass prefillable syringe system specifically engineered for the administration of biopharmaceutical injectable drugs. This new product is designed to address industry challenges in developing,...

2013-05-24 16:22:59

FRANKLIN LAKES, N.J., May 24, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the Deutsche Bank 38(th) Annual Health Care Conference on Thursday, May 30, 2013, at 10:40 a.m. (ET). A live webcast of BD's presentation can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, June 6, 2013. About BD BD is a leading global...

2013-05-22 08:28:05

A Shared Value Approach FRANKLIN LAKES, N.J., May 22, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the publication of its 2012 Sustainability Report. This is BD's fifth Sustainability Report and it continues to focus on the Company's shared value approach to sustainability. "We believe the principles of shared value -- creating value for shareholders by strengthening communities and addressing...

2013-05-21 12:28:15

FRANKLIN LAKES, N.J., May 21, 2013 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of 49.5 cents per common share, payable on June 28, 2013 to holders of record on June 7, 2013. The indicated annual dividend rate is $1.98 per share. About BDBD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated...

2013-05-02 08:35:17

FRANKLIN LAKES, N.J., May 2, 2013 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $2.0 billion for the second fiscal quarter ended March 31, 2013, representing an increase of 3.7 percent from the prior-year period, or 4.1 percent on a foreign currency-neutral basis. "We continued to deliver solid performance in the second quarter. Our results for the first half of the year give us the...

2013-04-27 04:20:29

SPARKS, Md., April 27, 2013 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company), announced today an international distributor agreement with Bruker Daltonics Inc. to sell and provide front-line technical support for the co-labeled BD(TM) Bruker MALDI Biotyper(TM) System. Microbial identification and antimicrobial susceptibility testing is the end-point of the majority of work a microbiology lab performs on a daily basis and is very time consuming. The BD(TM)...

2013-04-23 08:34:03

Approval Follows Recent Launch of Generic Prefilled Injectables FRANKLIN LAKES, N.J., April 23, 2013 /PRNewswire/ -- BD Rx Inc., a wholly-owned subsidiary of leading global medical technology company BD (Becton, Dickinson and Company) (NYSE:BDX), announced today that the U.S. Food and Drug Administration (FDA) has approved the second drug to be offered in the recently launched BD Simplist(TM) line of ready-to-administer prefilled generic injectables. The second BD Simplist product...

2013-04-17 08:26:46

National Safe Handling Awareness Month Webinar Calls Attention to Hazardous Drug Handling, Safety Precautions and Standards FRANKLIN LAKES, N.J., April 17, 2013 /PRNewswire/ -- While the Occupational Safety and Health Administration (OSHA) has classified chemotherapy drugs - which are designed to be toxic and highly absorbable in order to fight cancers - as hazardous since the 1980s, there are insufficient federal or state regulations to limit healthcare workers' exposure to these...

2013-04-11 08:28:46

New Safety Device Designed to Support the Needs of Biologics FRANKLIN LAKES, N.J., April 11, 2013 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the commercial launch of a new passive needle guard technology, BD UltraSafe PLUS(TM). The BD UltraSafe PLUS(TM) Passive Needle Guard has received 510(k) clearance as an anti-needlestick safety device. This product, in addition to offering...